Tag: Myrobalan Therapeutics

Myrobalan Therapeutics has filed a notice of an exempt offering of securities to raise $24,049,258.00 in New Equity Investment.

Myrobalan Therapeutics has filed a notice of an exempt offering of securities to raise $24,049,258.00 in New Equity Investment.

According to filings with the U.S. Securities and Exchange Commission, Myrobalan Therapeutics is raising up to $24,049,258.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Jing Wang played a…

Read More Read More

Myrobalan Therapeutics Completes Series A Financing of $24 Million to Develop Potentially First-in-Class CNS Therapeutics with Restorative Potential

Myrobalan Therapeutics Completes Series A Financing of $24 Million to Develop Potentially First-in-Class CNS Therapeutics with Restorative Potential

Approach leverages novel mechanisms such as remyelination and anti-neuroinflammation to address a broad spectrum of degenerative CNS diseases Myrobalan has designed a portfolio of highly selective, orally available compounds with the potential for superior brain…

Read More Read More